I-131 MIBG(I-131 Meta-Iodobenzylguanidine) radiotherapy for malignant neuroendocrine tumors
Not Applicable
- Conditions
- malignant neuroendocrine tumors
- Registration Number
- JPRN-UMIN000017057
- Lead Sponsor
- Kagoshima university hospital Department of Radiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Under pregnant or breast feeding Life expectancy less than 1 month Renal disorder (GFR<30ml/min) Limited bone marrow capacity (WBC<3000,platelet<100,000) Understanding and cooperation cannnot be obtained from family members When medical staff determine that treatment cannot be properly carried out.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method